EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics

Reed L Berkowitz iD, Andrew P Bluhm, Glenn W Knox, Christopher R McCurdy iD, David A Ostrov iD, Michael H Norris iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Reed L Berkowitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: COVID-19, Receptors, sigma. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florida College of Pharmacy- Pharmacy Recurring Opportunity Seed Program for Education and Research (PROSPER) Excellence Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of lethal coronaviruses follows a periodic pattern which suggests a recurring cycle of outbreaks. It remains uncertain as to when the next lethal coronavirus will emerge, though its eventual emergence appears to be inevitable. New mutations in evolving SARS-CoV-2 variants have provided resistance to current antiviral drugs, monoclonal antibodies, and vaccines, reducing their therapeutic efficacy. This underscores the urgent need to investigate alternative therapeutic approaches. Sigma receptors have been unexpectedly linked to the SARS-CoV-2 life cycle due to the direct antiviral effect of their ligands. Coronavirus-induced cell stress facilitates the formation of an ER-derived complex conducive to its replication. Sigma receptor ligands are believed to prevent the formation of this complex. Repurposing FDA-approved drugs for COVID-19 offers a timely and cost-efficient strategy to find treatments with established safety profiles. Notably, diphenhydramine, a sigma receptor ligand, is thought to counteract the virus by inhibiting the creation of ER-derived replication vesicles. Furthermore, lactoferrin, a well-characterized immunomodulatory protein, has shown antiviral efficacy against SARS-CoV-2 both in laboratory settings and in living organisms. In the present study, we aimed to explore the impact of sigma receptor ligands on SARS-CoV-2-induced mortality in ACE2-transgenic mice. We assessed the effects of an investigational antiviral drug combination comprising a sigma receptor ligand and an immunomodulatory protein. Mice treated with sigma-2 receptor ligands or diphenhydramine and lactoferrin exhibited improved survival rates and rapid rebound in mass following the SARS-CoV-2 challenge compared to mock-treated animals. Clinical translation of these findings may support the discovery of new treatment and research strategies for SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Receptors, sigmaAnimalsMiceSARS-CoV-2Antiviral AgentsLactoferrinLigandsDiphenhydramine

Stichwörter der Autor:innen

COVIDSARS-CoV-2antiviral resistanceantiviralscoronavirusesdiphenhydraminelactoferrinmutationssigma receptorstherapeuticstreatment strategiesvaccinesvariants

Substanzen

Receptors, sigmaAntiviral AgentsLactoferrinLigandsDiphenhydramine

Autor:innen und Institutionen

  • Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Spatial Epidemiology and Ecology Research Laboratory, Department of Geography, College of Liberal Arts and Sciences, University of Florida, Gainesville, FL 32611, USA.
  • Emerging Pathogens Institute, University of Florida, Gainesville, FL 32601, USA.
  • Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
  • Translational Drug Development Core, Clinical and Translational Sciences Institute, University of Florida, Gainesville, FL 32610, USA.
  • School of Life Sciences, University of Hawai'i at Mānoa, Honolulu, HI 96822, USA.

ORCID-Profile: Reed L Berkowitz, Christopher R McCurdy, David A Ostrov, Michael H Norris

Förderung

  • University of Florida College of Pharmacy- Pharmacy Recurring Opportunity Seed Program for Education and Research (PROSPER) Excellence Award

Zitieren

APA

Berkowitz, R. L., Bluhm, A. P., Knox, G. W., McCurdy, C. R., Ostrov, D. A., & Norris, M. H. (2023). Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115718

Vancouver

Berkowitz RL, Bluhm AP, Knox GW, McCurdy CR, Ostrov DA, Norris MH. Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115718

BibTeX
@article{Berkowitz2023,
  author = {Berkowitz, Reed L and Bluhm, Andrew P and Knox, Glenn W and McCurdy, Christopher R and Ostrov, David A and Norris, Michael H},
  title = {Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115718}
}
Kostenlos starten →